Matrix metalloproteinase 3 promotes cellular anti-dengue virus response via interaction with transcription factor NFkB in cell nucleus

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Zuo, Xiangyang ^a   Pan, Wen ^a   Feng, Tingting ^a   Shi, Xiaohong ^a   Dai, Jianfeng ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STROMELYSIN; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CONTROLLED STUDY; CYTOKINE RESPONSE; DENGUE; ENZYME ACTIVITY; ENZYME LOCALIZATION; IMMUNOMODULATION; IN VITRO STUDY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS LOAD; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL LINE; CELL NUCLEUS; CYTOKINES; CYTOPLASM; DENGUE VIRUS; DOWN-REGULATION; GENE SILENCING; HUMANS; MATRIX METALLOPROTEINASE 3; MICE; NF-KAPPA B; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84897105844     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084748     Document Type: Article

References (35)

1. Narvaez F, Gutierrez G, Perez MA, Elizondo D, Nunez A, et al. (2011) Evaluation of the traditional and revised WHO classifications of Dengue disease severity. PLoS Negl Trop Dis 5: e1397.
2. Whitehorn J, Simmons CP (2011) The pathogenesis of dengue. Vaccine 29: 7221-7228.
3. Murphy BR, Whitehead SS (2011) Immune response to dengue virus and prospects for a vaccine. Annu Rev Immunol 29: 587-619.
4. Liu SY, Sanchez DJ, Cheng G (2011) New developments in the induction and antiviral effectors of type I interferon. Curr Opin Immunol 23: 57-64.
5. Rawlings JS, Rosler KM, Harrison DA (2004) The JAK/STAT signaling pathway. J Cell Sci 117: 1281-1283.
6. Schindler C, Plumlee C (2008) Inteferons pen the JAK-STAT pathway. Semin Cell Dev Biol 19: 311-318.
7. Platanias LC (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5: 375-386.
8. Murray PJ (2007) The JAK-STAT signaling pathway: input and output integration. J Immunol 178: 2623-2629.
9. Thangaraju M, Rudelius M, Bierie B, Raffeld M, Sharan S, et al. (2005) C/EBPdelta is a crucial regulator of pro-apoptotic gene expression during mammary gland involution. Development 132: 4675-4685.
10. Rodríguez D, Morrison CJ, Overall CM (2010) Matrix metalloproteinases: What do they not do? New substrates and biological roles identified by murine models and proteomics. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1803: 39-54.
11. Visse R (2003) Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function, and Biochemistry. Circulation Research 92: 827-839.
12. Parks WC, Wilson CL, Lopez-Boado YS (2004) Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 4: 617-629.
13. Manicone A, McGuire J (2008) Matrix metalloproteinases as modulators of inflammation. Seminars in Cell & Developmental Biology 19: 34-41.
14. McMillan SJ, Kearley J, Campbell JD, Zhu XW, Larbi KY, et al. (2004) Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation. J Immunol 172: 2586-2594.
15. Wang P, Dai J, Bai F, Kong KF, Wong SJ, et al. (2008) Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain. J Virol 82: 8978-8985.
16. Kim YS (2005) Matrix Metalloproteinase-3: A Novel Signaling Proteinase from Apoptotic Neuronal Cells That Activates Microglia. Journal of Neuroscience 25: 3701-3711.
17. Kim E-M, Hwang O (2011) Role of matrix metalloproteinase-3 in neurodegeneration. Journal of Neurochemistry 116: 22-32.
18. Kim EM, Shin EJ, Choi JH, Son HJ, Park IS, et al. (2010) Matrix metalloproteinase-3 is increased and participates in neuronal apoptotic signaling downstream of caspase-12 during endoplasmic reticulum stress. J Biol Chem 285: 16444-16452.
19. Walker EJ, Rosenberg GA (2009) TIMP-3 and MMP-3 contribute to delayed inflammation and hippocampal neuronal death following global ischemia. Exp Neurol 216: 122-131.
20. Wetzel M, Rosenberg GA, Cunningham LA (2003) Tissue inhibitor of metalloproteinases-3 and matrix metalloproteinase-3 regulate neuronal sensitivity to doxorubicin-induced apoptosis. Eur J Neurosci 18: 1050-1060.
21. Woo M-S, Park J-S, Choi I-Y, Kim W-K, Kim H-S (2008) Inhibition of MMP-3 or -9 suppresses lipopolysaccharide-induced expression of proinflammatory cytokines and iNOS in microglia. Journal of Neurochemistry 106: 770-780.
22. White LA (1987) Susceptibility of Aedes albopictus C6/36 cells to viral infection. J Clin Microbiol 25: 1221-1224.
23. Dai J, Pan W, Wang P (2011) ISG15 facilitates cellular antiviral response to dengue and west nile virus infection in vitro. Virol J 8: 468.
24. Pascual G, Glass CK (2006) Nuclear receptors versus inflammation: mechanisms of transrepression. Trends in Endocrinology & Metabolism 17: 321-327.
25. Ivashkiv LB (2011) Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states. Eur J Immunol 41: 2477-2481.
26. Eguchi T, Kubota S, Kawata K, Mukudai Y, Uehara J, et al. (2008) Novel transcription-factor-like function of human matrix metalloproteinase 3 regulating the CTGF/CCN2 gene. Mol Cell Biol 28: 2391-2413.
27. Mannello F, Medda V (2012) Nuclear localization of matrix metalloproteinases. Prog Histochem Cytochem 47: 27-58.
28. Si-Tayeb K, Monvoisin A, Mazzocco C, Lepreux S, Decossas M, et al. (2006) Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis. Am J Pathol 169: 1390-1401.
29. Ruta A, Mark B, Edward B, Jawaharlal P, Jianliang Z (2009) Nuclear Localization of Active Matrix Metalloproteinase-2 in Cigarette Smoke-Exposed Apoptotic Endothelial Cells. Experimental Lung Research 35: 59-75.
30. Cuadrado E, Rosell A, Borrell-Pages M, Garcia-Bonilla L, Hernandez-Guillamon M, et al. (2009) Matrix metalloproteinase-13 is activated and is found in the nucleus of neural cells after cerebral ischemia. J Cereb Blood Flow Metab 29: 398-410.
31. Ip YC, Cheung ST, Fan ST (2007) Atypical localization of membrane type 1-matrix metalloproteinase in the nucleus is associated with aggressive features of hepatocellular carcinoma. Mol Carcinog 46: 225-230.
32. Cousin H, Abbruzzese G, Kerdavid E, Gaultier A, Alfandari D (2011) Translocation of the Cytoplasmic Domain of ADAM13 to the Nucleus Is Essential for Calpain8-a Expression and Cranial Neural Crest Cell Migration. Developmental Cell 20: 256-263.
33. Baek SH, Ohgi KA, Rose DW, Koo EH, Glass CK, et al. (2002) Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell 110: 55-67.
34. Souslova V, Townsend PA, Mann J, van der Loos CM, Motterle A, et al. (2010) Allele-specific regulation of matrix metalloproteinase-3 gene by transcription factor NFkappaB. PLoS One 5: e9902.
35. Li CK, Pender SL, Pickard KM, Chance V, Holloway JA, et al. (2004) Impaired immunity to intestinal bacterial infection in stromelysin-1 (matrix metalloproteinase-3)-deficient mice. J Immunol 173: 5171-5179.